[Biomarkers for the diagnosis of cognitive impairment - Recommendations from the Swiss Memory Clinics]. - Publikation

Publikation

[Biomarkers for the diagnosis of cognitive impairment - Recommendations from the Swiss Memory Clinics].

Wissenschaftlicher Artikel/Review - 14.12.2022

Popp Julius, Georgescu Dan, Bürge Markus, Mundwiler-Pachlatko Esther, Bernasconi Luca, Felbecker Ansgar

Zitation

Popp J, Georgescu D, Bürge M, Mundwiler-Pachlatko E, Bernasconi L, Felbecker A. [Biomarkers for the diagnosis of cognitive impairment - Recommendations from the Swiss Memory Clinics]. Rev Med Suisse 2022; 18:2400-2405.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Rev Med Suisse 2022; 18

Veröffentlichungsdatum

14.12.2022

ISSN (Druck)

1660-9379

Seiten

2400-2405

Kurzbeschreibung/Zielsetzung

Established cerebrospinal fluid (CSF) biomarkers allow for earlier and more accurate etiological diagnosis of cognitive impairment. Information and counselling are needed both before and after biomarker-supported diagnosis. The procedures for diagnostic lumbar punctures and pre-analytical sample handling should follow published consensus recommendations. The results must be interpreted in the context of the other available history information and assessments. Blood-based biomarkers and other non-invasive markers are expected to become available for clinical practice soon. Consequently, a broader usage of biomarkers is expected and may accelerate the development of individually tailored prevention and treatment approaches. This article provides the recommendations of the Swiss Memory Clinics for the use of biomarkers in clinical practice.